No description available.

Staphylococcus aureus causes an assortment of infections that range from mild skin infections to bacteremia or necrotizing pneumonia. Patients with S. aureus infections may suffer poor outcomes such as extended hospital stay and death. The goal of this study was to improve outcomes of patients with S. aureus infections by examining microbial characteristics of S. aureus associated with poor clinical outcomes, and comparative effectiveness of S. aureus treatment options for patients with S. aureus infections. Additionally, methods to prevent S. aureus infections among hospitalized patients were assessed. We performed a two-hospital retrospective cohort study to identify microbial characteristics, patient characteristics, or antimicrobial treatments that were predictors of mortality or length of stay among patients with methicillin-resistant S. aureus (MRSA) pneumonia. We found increased age (> 54 years) (hazard ratio [HR]: 4.49; 95% confidence interval [CI]: 1.64-12.33), intensive care unit (ICU) admission (HR: 5.25; CI: 1.52-18.21), and having a hospital-onset pneumonia (HR: 0.32; CI: 0.13-0.75) were associated with mortality while admission to the ICU (odds ratio [OR]: 7.34; CI: 3.58-15.04), increased age (> 54 years) (OR: 2.27; CI: 1.19-4.35), having a hospital-onset pneumonia (OR: 3.60; CI: 1.26-10.28), and receiving vancomycin (OR: 10.85; CI: 3.68-32.00) were predictors of increased length of stay. None of the tested microbial characteristics were associated with poor outcomes. We also completed a multicenter retrospective cohort study to compare the effect of beta-lactams versus vancomycin (both empiric and definitive therapy) on mortality for patients with methicillin-susceptible S. aureus (MSSA) bacteremia who were admitted to Veteran Affairs Medical Centers. We found an increased hazard of mortality for patients who received empiric treatment with a beta-lactam compared with vancomycin (HR: 1.19, 95% CI: 1.00-1.42). However, we observed a protective effect among patients who received definitive treatment with a beta-lactam compared with vancomycin (HR: 0.66; CI: 0.50-0.87). In 2007, 2009-2011, we administered surveys that focused on the implementation of the Institute for Healthcare Improvement's (IHI) MRSA bundle to reduce hospital-onset MRSA infections to infection preventionsts who worked in Iowa hospitals. By the end of the study period, most hospitals implemented a hand hygiene program (range: 87%-94%), placed infected (range: 97%-100%) or colonized patients (range: 77%-92%) on contact precautions, performed active surveillance culturing to identify colonized patients, and monitored the effectiveness of environmental cleaning (range: 23%-71%; P < 0.001). To improve patient outcomes, physicians should provide beta-lactams for definitive treatment of patients with MSSA bacteremia. However, the most effective method to improve outcomes is to prevent S. aureus infections from occurring. This study provides benchmark data that infection prevention staff in rural hospitals throughout the U.S. can use to compare their practices with Iowa hospitals.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Staphylococcus aureus resistente à meticilina (MRSA) é um importante patógeno pulmonar em pacientes com fibrose cística (FC). Caracteriza-se pela resistência a todos os &#946;-lactâmicos, devido a presença do elemento genético móvel SCCmec o qual abriga o gene mecA. Além disso, é reconhecido por vários fatores de virulência o qual destacamos a toxina Panton-Valentine Leukocidin (PVL), uma citolisina formadora de poros na célula hospedeira, e por apresentar diversos clones epidêmicos envolvidos em surtos hospitalares. O objetivo desse estudo foi caracterizar a epidemiologia de MRSA, isolados de pacientes com FC referente a dois centros de referência no Rio de Janeiro a partir da aplicação de técnicas fenotípicas e genotípicas. Um total de 57 amostras de MRSA foi submetido ao teste de difusão em ágar para 11 antimicrobianos a fim de avaliar perfil de resistência, com aplicação da técnica da PCR foi tipificado o SCCmec e investigado a presença do gene LukS-PV responsável pela codificação da toxina PVL com intuito de estabelecer uma melhor caracterização epidemiológica dos clones identificados pela técnica do MLST (Multilocus Sequence Typing). Os antimicrobianos não &#946;-lactâmicos apresentaram um percentual de resistência abaixo de 50%, em que destacamos a eritromicina com o maior percentual 45,6% e quanto ao perfil de resistência 24,6% foram multirresistentes. Com exceção do SCCmec II, os outros tipos foram encontrados (I, III, IV e V) com os respectivos percentuais de 22,8% (n=13), 7,1% (n=4), 61,4% (n=35) e 3,5% (n=2) e apenas 5,3% (n=3) das amostras não foram caracterizadas, não há dados da prevalência do SCCmec IV. Vinte (35,1%) amostras apresentaram produtos de amplificação compatível com a presença do gene lukS, aproximadamente metade dessas amostras (55%) estava correlacionada ao SCCmec IV. Com a análise do MLST, obtivemos os STs 1 (n=1, 1,7%), 5 (n=28, 49,1%), 30 (n=11, 19,3%), 72 (n=1, 1,7%), 398 (n=1, 1,7%), 1635 (n=7, 12,3%), 1661 (n=2, 3,5%), 239 (n=5, 8,8%), e ainda identificamos um novo ST (2732) presente em 1 amostra. A partir de uma análise associativa entre o MLST e o SCCmec foi possível observar a presença de linhagens características de clones epidêmicos, como o UK-EMRSA-3 (ST5, SCCmec I), USA 800/pediátrico (ST5, SCCmec IV), Oceania Southwest Pacific Clone - OSPC (ST30, SCCmec IV) e Brazilian Epidemic Clone - BEC (ST239, SCCmec III). Em conclusão este estudo é o primeiro a caracterizar linhagens epidêmicas de MRSA nos centros de atendimento a pacientes com FC no Rio de Janeiro, sendo necessário um monitoramento constante a fim de evitar a disseminação desses clones. / Methicillin-resistant Staphylococcus aureus (MRSA) is a major pulmonary pathogen in patients with cystic fibrosis (CF). It is characterized by resistance to all &#946;-lactam antibiotics due to the presence of the mobile genetic element SCCmec which harbors the mecA gen. Furthermore, MRSA is recognized by several virulence factors, such as the toxin Panton-Valentine Leukocidin (PVL), pore-forming cytolysin in the host cell, and produces various epidemic clones involved in hospital outbreaks. The aim of this study was to characterize the epidemiology of MRSA, using phenotypic and genotypic methods of isolates from CF patients from two reference centers in Rio de Janeiro. A total of 57 MRSA isolates were tested by the Agar diffusion test for 11 antibiotics. SCCmec and the presence of the Luks-PV gene, responsible for encoding the PVL toxin, were evoluted by PCR, in order to establish a better epidemiological clone characterization by MLST (Multilocus Sequence Typing) technique. Non-&#946;-lactam antimicrobials showed less than 50% of resistance, which included erythromycin with the highest percentage was 45.6%, beside, multirresistant profile was observed in 24.6% of isolates. We found SCCmec types I, III, IV and V with the corresponding percentage of 22.8% (n = 13), 7.1% (n = 4), 61.4% (n = 35) and 3.5% (n = 2) respectively and just 5.3% (n = 3) isolates were not typified. SCCmec II was not detected among our isolates. Twenty (35.1%) isolates showed amplification products consistent with the presence of the lukS gen, approximately half of these samples (55%) were correlated with SCCmec IV. Using MLST analysis, we obtained STs 1 (n = 1, 1.7%), 5 (n = 28, 49.1%), 30 (n = 11, 19.3%), 72 (n = 1, 1.7%), 398 (n = 1, 1.7%), 1635 (n = 7, 12.3%), 1661 (n = 2, 3.5%), 239 (n = 5, 8, 8%), and further identified a new ST (2732) present in one isolate. Associating MLST and SCCmec, it was possible to observe the presence of epidemic clones, such as, UK-EMRSA-3 (ST5, SCCmec I), USA800/pediatric (ST5, SCCmec IV), Oceania Southwest Pacific Clone - OSPC (ST30, SCCmec IV) and Brazilian Epidemic Clone - BEC (ST239, SCCmec III). In conclusion this study is the first one to characterize epidemic strains of MRSA in care centers of CF patients in Rio de Janeiro, that require constant monitoring in order to prevent the spread of these clones.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Staphylococcus aureus resistente à meticilina (MRSA) é um importante patógeno pulmonar em pacientes com fibrose cística (FC). Caracteriza-se pela resistência a todos os &#946;-lactâmicos, devido a presença do elemento genético móvel SCCmec o qual abriga o gene mecA. Além disso, é reconhecido por vários fatores de virulência o qual destacamos a toxina Panton-Valentine Leukocidin (PVL), uma citolisina formadora de poros na célula hospedeira, e por apresentar diversos clones epidêmicos envolvidos em surtos hospitalares. O objetivo desse estudo foi caracterizar a epidemiologia de MRSA, isolados de pacientes com FC referente a dois centros de referência no Rio de Janeiro a partir da aplicação de técnicas fenotípicas e genotípicas. Um total de 57 amostras de MRSA foi submetido ao teste de difusão em ágar para 11 antimicrobianos a fim de avaliar perfil de resistência, com aplicação da técnica da PCR foi tipificado o SCCmec e investigado a presença do gene LukS-PV responsável pela codificação da toxina PVL com intuito de estabelecer uma melhor caracterização epidemiológica dos clones identificados pela técnica do MLST (Multilocus Sequence Typing). Os antimicrobianos não &#946;-lactâmicos apresentaram um percentual de resistência abaixo de 50%, em que destacamos a eritromicina com o maior percentual 45,6% e quanto ao perfil de resistência 24,6% foram multirresistentes. Com exceção do SCCmec II, os outros tipos foram encontrados (I, III, IV e V) com os respectivos percentuais de 22,8% (n=13), 7,1% (n=4), 61,4% (n=35) e 3,5% (n=2) e apenas 5,3% (n=3) das amostras não foram caracterizadas, não há dados da prevalência do SCCmec IV. Vinte (35,1%) amostras apresentaram produtos de amplificação compatível com a presença do gene lukS, aproximadamente metade dessas amostras (55%) estava correlacionada ao SCCmec IV. Com a análise do MLST, obtivemos os STs 1 (n=1, 1,7%), 5 (n=28, 49,1%), 30 (n=11, 19,3%), 72 (n=1, 1,7%), 398 (n=1, 1,7%), 1635 (n=7, 12,3%), 1661 (n=2, 3,5%), 239 (n=5, 8,8%), e ainda identificamos um novo ST (2732) presente em 1 amostra. A partir de uma análise associativa entre o MLST e o SCCmec foi possível observar a presença de linhagens características de clones epidêmicos, como o UK-EMRSA-3 (ST5, SCCmec I), USA 800/pediátrico (ST5, SCCmec IV), Oceania Southwest Pacific Clone - OSPC (ST30, SCCmec IV) e Brazilian Epidemic Clone - BEC (ST239, SCCmec III). Em conclusão este estudo é o primeiro a caracterizar linhagens epidêmicas de MRSA nos centros de atendimento a pacientes com FC no Rio de Janeiro, sendo necessário um monitoramento constante a fim de evitar a disseminação desses clones. / Methicillin-resistant Staphylococcus aureus (MRSA) is a major pulmonary pathogen in patients with cystic fibrosis (CF). It is characterized by resistance to all &#946;-lactam antibiotics due to the presence of the mobile genetic element SCCmec which harbors the mecA gen. Furthermore, MRSA is recognized by several virulence factors, such as the toxin Panton-Valentine Leukocidin (PVL), pore-forming cytolysin in the host cell, and produces various epidemic clones involved in hospital outbreaks. The aim of this study was to characterize the epidemiology of MRSA, using phenotypic and genotypic methods of isolates from CF patients from two reference centers in Rio de Janeiro. A total of 57 MRSA isolates were tested by the Agar diffusion test for 11 antibiotics. SCCmec and the presence of the Luks-PV gene, responsible for encoding the PVL toxin, were evoluted by PCR, in order to establish a better epidemiological clone characterization by MLST (Multilocus Sequence Typing) technique. Non-&#946;-lactam antimicrobials showed less than 50% of resistance, which included erythromycin with the highest percentage was 45.6%, beside, multirresistant profile was observed in 24.6% of isolates. We found SCCmec types I, III, IV and V with the corresponding percentage of 22.8% (n = 13), 7.1% (n = 4), 61.4% (n = 35) and 3.5% (n = 2) respectively and just 5.3% (n = 3) isolates were not typified. SCCmec II was not detected among our isolates. Twenty (35.1%) isolates showed amplification products consistent with the presence of the lukS gen, approximately half of these samples (55%) were correlated with SCCmec IV. Using MLST analysis, we obtained STs 1 (n = 1, 1.7%), 5 (n = 28, 49.1%), 30 (n = 11, 19.3%), 72 (n = 1, 1.7%), 398 (n = 1, 1.7%), 1635 (n = 7, 12.3%), 1661 (n = 2, 3.5%), 239 (n = 5, 8, 8%), and further identified a new ST (2732) present in one isolate. Associating MLST and SCCmec, it was possible to observe the presence of epidemic clones, such as, UK-EMRSA-3 (ST5, SCCmec I), USA800/pediatric (ST5, SCCmec IV), Oceania Southwest Pacific Clone - OSPC (ST30, SCCmec IV) and Brazilian Epidemic Clone - BEC (ST239, SCCmec III). In conclusion this study is the first one to characterize epidemic strains of MRSA in care centers of CF patients in Rio de Janeiro, that require constant monitoring in order to prevent the spread of these clones.

Submitted by Erika Demachki (erikademachki@gmail.com) on 2017-01-06T18:29:27Z No. of bitstreams: 2 Dissertação - Jéssica de Oliveira Veloso - 2016.pdf: 2794813 bytes, checksum: 8bd9adfbbc795e1b905411f5c2a04d01 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2017-01-09T09:47:16Z (GMT) No. of bitstreams: 2 Dissertação - Jéssica de Oliveira Veloso - 2016.pdf: 2794813 bytes, checksum: 8bd9adfbbc795e1b905411f5c2a04d01 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2017-01-09T09:47:16Z (GMT). No. of bitstreams: 2 Dissertação - Jéssica de Oliveira Veloso - 2016.pdf: 2794813 bytes, checksum: 8bd9adfbbc795e1b905411f5c2a04d01 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2016-09-30 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Staphylococcus aureus is an important pathogen related to nosocomial infections, with high prevalence, morbidity and mortality rates. In this context, the Intensive Care Units (ICU) has been high-risk areas for the selection of multiresistant strains. The environment (objects, equipment and surfaces) of an ICU can also get contaminated, and microorganisms may remain viable for a long period of time, and can colonize patients, employees, visitors and other environments. The objectives of the study were to determine the prevalence of S. aureus contamination in patients and ICU environment of a university hospital in the city of Goiânia-GO, as well as to determine the antimicrobial susceptibility and virulence profile of the isolates and perform molecular typing of methicillin-resistant S. aureus (MRSA) isolates. The isolation and presumptive identification of S. aureus by phenotypic techniques and the confirmation of the species by detection of femA gene by PCR were performed. The isolates were subjected to diskdiffusion test for determining antimicrobial susceptibility profile, and those showing resistance to cefoxitin were subjected to E-Test® to determine the minimum inhibitory concentration (MIC) to oxacillin and vancomycin, as well as the mecA gene detection for identification of MRSA strains. In these isolates the SCCmec typing was performed. In all S. aureus isolates were detected virulence factors-coding genes and held the genetic comparison for determining the similarity profile by pulsed field gel electrophoresis. Fifty hundred and thirty six swabs were collected being 134 of patients and 402 of ICU environment. The prevalence of colonization by S. aureus was 12.7% (68/536), being 13.4% (18/134) for patients and 12.4% (50/402) for the environment. The highest resistance rate presented was to penicillin (85.3%) followed by erythromycin (69.1%) clindamycin (66.2%) and sulfamethoxazole-trimethoprim (54.4%). Fifty-six isolates (82.4%) were classified as multiresistant. The prevalence of MRSA was 20.6% (14/68), and seven isolates (10.3%) presented intermediate susceptibility to vancomycin (VISA). The inducible resistance phenotype (iMLSb) was found in 11 strains (16.2%) and the constitutive resistance (cMLSb) in 25 (36.8%). Eleven isolates showed genes encoding for at least one virulence factor and were detected six virulence profiles. Of the 14 MRSA strains, six (42.9%) were SCCmec type IV, five (35.7%) SCCmec type I, two (14.3%) SCCmec type II and one (7.1%) SCCmec type III. PFGE analysis showed genetic diversity among the isolates, although a cluster grouped 16 isolates showing the spread of the bacteria among patients and environment. One MRSA isolate showed genetic relationship to the USA300 strain and two isolates MRSA/VISA were similar and another identical to the clone USA400. The results suggest that the prevalence of S. aureus and MRSA remains high in health institutions, especially in the ICU, with high rates of antimicrobial resistance and pathogenic potential. The detection of these microorganisms in the environment shows risk of cross-transmission primarily via health professionals. Identification of isolates with genetic background of strains acquired in the community alert to a flow of intra and inter- hospital and community environment. In addition, it is believed that environmental surfaces can be acting as reservoirs of genes of resistance and virulence as well as potential sources of contamination to patients, professionals and environments. / Staphylococcus aureus é um importante patógeno relacionado a infecções nosocomiais, com elevadas taxas de prevalência, morbidade e mortalidade. Nesse contexto, as Unidades de Terapia Intensiva (UTI) tem sido áreas de alto risco para a seleção de cepas multirresistentes. O ambiente (objetos, equipamentos e superfícies) de uma UTI também pode se contaminar, e os microrganismos podem permanecer viáveis por um longo período de tempo, podendo colonizar pacientes, trabalhadores, visitantes e contaminar ainda outros ambientes. Os objetivos do estudo foram determinar a prevalência de colonização por S. aureus em pacientes e ambiente da UTI de um hospital universitário na cidade de Goiânia-GO, bem como o perfil de susceptibilidade antimicrobiana e perfil de virulência dos isolados e realizar a tipagem molecular dos S. aureus resistentes à meticilina (MRSA). Foi realizado o isolamento e identificação presuntiva de S. aureus por técnicas fenotípicas e a confirmação da espécie pela detecção do gene femA por PCR. Os isolados foram submetidos ao teste de disco-difusão para determinação do perfil de suscetibilidade antimicrobiana e aqueles que apresentaram resistência à cefoxitina foram submetidos ao E-test® para determinação da concentração inibitória mínima à oxacilina e vancomicina, assim como, à detecção do gene mecA para identificação das cepas MRSA. Nestes isolados foi realizada a tipagem do SCCmec. Em todos os S. aureus isolados foi realizada a detecção dos genes codificadores de fatores de virulência e a comparação genética para determinação do perfil de similaridade por eletroforese em gel em campo pulsado. Foram coletados 536 swabs sendo 134 de pacientes e 402 de ambiente de UTI. A prevalência de colonização por S. aureus foi de 12,7% (68/536), sendo 13,4% (18/134) para pacientes e 12,4% (50/402) para o ambiente. A maior taxa de resistência apresentada foi à penicilina (85,3%) seguida da eritromicina (69,1%), clindamicina (66,2%) e sulfametoxazol-trimetoprim (54,4%). Cinquenta e seis isolados (82,4%) foram considerados multirresistentes. A prevalência de MRSA foi de 20,6% (14/68), houve ainda a existência de sete (10,3%) isolados com suscetibilidade intermediária à vancomicina (VISA). O fenótipo de resistência induzível (iMLSb) foi encontrado em 11 isolados (16,2%) e o de resistência constitutiva (cMLSb) em 25 (36,8%). Onze isolados apresentaram genes codificadores para pelo menos um fator de virulência pesquisado, sendo detectados seis perfis de virulência. Das 14 cepas MRSA, seis (42,9%) foram SCCmec tipo IV, cinco (35,7%) SCCmec tipo I, duas (14,3%) SCCmec tipo II e uma (7,1%) SCCmec tipo III.A análise de PFGE revelou diversidade genética entre os isolados, apesar de que um cluster agrupou 16 isolados mostrando a disseminação da bactéria entre pacientes e fômites. Um isolado MRSA mostrou relacionamento genético à cepa USA300 e dois isolados MRSA/VISA foram semelhantes e outro idêntico ao clone USA400. Os resultados sugerem que a prevalência de S. aureus e MRSA permanece elevada em instituições de saúde, especialmente em UTI, com elevadas taxas de resistência antimicrobiana e potencial patogênico. A detecção desses microrganismos no ambiente evidencia risco de transmissão cruzada desses patógenos, principalmente via profissionais da saúde. A identificação de isolados com background genético de cepas adquiridas na comunidade alerta para um fluxo de disseminação intra e inter-ambiente hospitalar e comunitário. Além disso, acredita-se que as superfícies ambientais podem estar atuando como reservatórios de genes de resistência e virulência, bem como fontes potenciais de contaminação de pacientes, profissionais e ambientes.

Clinical S. aureus strains were gathered from four hospitals, two in Turkey (Hacettepe hospital 200 strains and Ankara Hospital 106 strains) and the other two from Libya (Aljalla Hospital 88 strains and Jamahyria Hospital 62 strains). The clinical specimens were collected form different sources including blood, urine, wound, pus, burn, sputum, semen, catheter and aspiration. Patients were aged between 0 to 84 years and from both sexes. Resistance to Methicillin was determined by measuring the Oxacillin MIC / this was done by using the oxacillin E-test, with resistance defined as an MIC of &gt / 2 &micro / g ml. In this study all isolates displayed an Oxacillin MIC of &amp / #8805 / 256&micro / g/ml. The MRSA strains were (56%) in Turkish hospitals, and (59%) in Libyan hospitals. The percentage of the VRSA and VISA in Libyan hospitals was (7%) and (26%) respectively, although the percentage of VRSA in Turkish hospitals was only 2% and there were no intermediately susceptible Staphylococcus aureus (VISA). Besides the MRSA isolates, Coagulase Negative Staphylococcus showing Methicillin resistance was collected from clinical isolates in thirteen patients in Turkish hospitals. In both countries, the majority MRSA isolates were multiresistant to more than five classes of antibiotics including / Ampicillin, Amoxicillin, Tetracycline, Erythromycin and Ciprofloxacin. Most of the MRSA isolates were from blood (68%), wounds (57%) and pus (50%).The results of genetic investigations indicated that the mecA gene was present in the majority of isolates in both countries / the community acquired MRSA type (ccr-BIV) was present in three samples out of thirty in Turkish hospitals and in one case out of twenty in Libyan hospitals / There was no case out of fifty specimens that carry the hospitals acquired MRSA type (ccr-BI, II, III) in both countries. Besides the Methicillin resistance gene, the incidence of Tetracycline resistance gene was quite high (tetM and tetK 50%) in Turkish hospitals isolates, and the prevalence of Panton-Valentine Leukocidin gene was high (PVL 70%) in Libyan hospitals specimens.

Staphylococcus aureus resistente à meticilina (MRSA) é um dos principais microrganismos envolvidos nas Infecções relacionadas à Assistência à Saúde (IrAS). Porém, um clone de MRSA, o CA-MRSA, emergiu na comunidade e atualmente vem sendo agente de IrAS. O objetivo desta dissertação é avaliar fenotípica e genotipicamente 111 amostras de Staphylococcus aureus resistentes à meticilina e sensíveis a antibióticos não ß-lactâmicos de pacientes atendidos em cinco hospitais no município do Rio de Janeiro. Utilizando os critérios padronizados pelo CLSI 2012, foram determinadas as susceptibilidades a 11 antimicrobianos pelo método de disco difusão em ágar e concentração inibitória mínima para vancomicina e oxacilina pelo método da microdiluição em caldo. A multirresistência (resistência a 3 ou mais antimicrobianos não ß-lactâmicos) foi observada em 31,5% das amostras, sendo que 53,2% apresentaram resistência ao antimicrobiano clindamicina, uma das opções para o tratamento empírico das infecções de pele/tecidos moles. 86,4% apresentaram concentração inibitória mínima (CIM) para vancomicina &#8805; 1,0 g/mL ou seja, elevado percentual de amostras associadas ao fenômeno MIC creep, o qual está associado ao insucesso na terapia antimicrobiana anti-MRSA. Não foi observado até o momento nenhuma amostra com CIM &#8805; 4cg/mL para vancomicina, entretanto, já há resistência à linezolida em quatro hospitais do estudo. A tipificação do SCCmec nos permitiu classificar 4,5% das amostras em HA-MRSA e 86,5% em CA-MRSA, nas quais a resistência heterogênea típica à oxacilina foi observada em 57,2%. A toxina de Panton-Valentine (PVL) foi identificada pela metodologia de PCR em 28% das amostras com genótipo CA-MRSA. Os fatores de riscos clássicos, da literatura, relacionados à infecção por HA-MRSA foram também observados nos pacientes com infecção por CA-MRSA portadoras de SCCmec IV e V. No intuito de verificar a existência de similaridades genéticas ou a presença de clone predominante entre as amostras dos cinco hospitais, foi realizada a técnica de eletroforese em gel sob campo pulsado (PFGE) e observou-se diversidade genética assim como a presença de amostras com padrões similares aos clones OSPC (18,5%) e USA400. Não foram encontradas amostras com padrões de eletroforese similares aos clones USA300, USA800 e CEB. É essencial a vigilância da resistência aos antimicrobianos não ß-lactâmicos no CA-MRSA, em especial à vancomicina. A mudança na epidemiologia deste microrganismo vem impactando os padrões característicos dos genótipos limitando os critérios de diferenciação entre eles. Neste contexto, as técnicas moleculares atuam como excelentes ferramentas de caracterização. O conhecimento do patógeno auxilia na elaboração e implementação de medidas preventivas, contribuindo para o controle da doença tanto no ambiente hospitalar quanto na comunidade. / Methicillin-resistant Staphylococcus aureus (MRSA) is a major microrganism involved in healthcare associated infections (HAIs). However, a clone of MRSA, CA-MRSA, has emerged in the community and has been considered agent of HAIs. The goal of this dissertation is to evaluate phenotypically and genotypically 111 samples of methicillin-resistant Staphylococcus aureus susceptible to non ß-lactam antibiotics from patients treated in five hospitals in the city of Rio de Janeiro. Using the Clinical and Laboratory Standards Institute criteria were determined susceptibility to 11 antimicrobials by the disk diffusion method and minimal inhibitory concentration for oxacillin and vancomycin by broth microdilution method. The multidrug resistance (resistance to three or more non ß-lactam antibiotics) was observed in 31.5% of isolates, and 53.2% were resistant to the antimicrobial clindamycin, one of the choices in the empirical treatment of infections of skin / soft tissue. 86.4% showed minimal inhibitory concentration (MIC) for vancomycin &#8805; 1.0 mg / mL, representing high percentage of samples associated with the MIC creep phenomenon, which can imply therapeutic failure. The typification of SCCmec enabled us to classify 4,5% of the samples in HA-MRSA and 86.5% in CA-MRSA, among which the typical heterogeneous oxacillin resistance was observed in 57.2%. The Panton-Valentine Leukocidin (PVL) toxin, one of the virulence factors involved in the pathogeneses of MRSA, was present in 28% of samples with genotype CA-MRSA. We performed uptake of demographic and clinical information on patients medical records and verified the presence of classical risk factors for HA-MRSA infection in individuals infected by CA-MRSA carrying SCCmec IV and V. In order to verify the existence of genetic similarities or the presence of predominant clone among the samples of the five hospitals, we applied the technique of pulsed-field gel electrophoresis (PFGE) and observed genetic diversity and the presence of samples with standards similar to OSPC clones (18.5%) and USA400. There were no samples with electrophoresis patterns similar to clone USA300, USA800 and CEB. Surveillance of resistance to non ß-lactam antibiotics is essencial in CA-MRSA, especially vancomycin. The change in the epidemiology of this microrganism has been impacting the characteristic patterns of genotypes limiting criteria of differentiation between them. In this context, molecular techniques serve as excellent characterization tools. Knowledge of pathogen assists in the development and implementation of preventive measures, contributing to disease control both in hospitals and in the community.

Staphylococcus aureus resistente à meticilina (MRSA) é um dos principais microrganismos envolvidos nas Infecções relacionadas à Assistência à Saúde (IrAS). Porém, um clone de MRSA, o CA-MRSA, emergiu na comunidade e atualmente vem sendo agente de IrAS. O objetivo desta dissertação é avaliar fenotípica e genotipicamente 111 amostras de Staphylococcus aureus resistentes à meticilina e sensíveis a antibióticos não ß-lactâmicos de pacientes atendidos em cinco hospitais no município do Rio de Janeiro. Utilizando os critérios padronizados pelo CLSI 2012, foram determinadas as susceptibilidades a 11 antimicrobianos pelo método de disco difusão em ágar e concentração inibitória mínima para vancomicina e oxacilina pelo método da microdiluição em caldo. A multirresistência (resistência a 3 ou mais antimicrobianos não ß-lactâmicos) foi observada em 31,5% das amostras, sendo que 53,2% apresentaram resistência ao antimicrobiano clindamicina, uma das opções para o tratamento empírico das infecções de pele/tecidos moles. 86,4% apresentaram concentração inibitória mínima (CIM) para vancomicina &#8805; 1,0 g/mL ou seja, elevado percentual de amostras associadas ao fenômeno MIC creep, o qual está associado ao insucesso na terapia antimicrobiana anti-MRSA. Não foi observado até o momento nenhuma amostra com CIM &#8805; 4cg/mL para vancomicina, entretanto, já há resistência à linezolida em quatro hospitais do estudo. A tipificação do SCCmec nos permitiu classificar 4,5% das amostras em HA-MRSA e 86,5% em CA-MRSA, nas quais a resistência heterogênea típica à oxacilina foi observada em 57,2%. A toxina de Panton-Valentine (PVL) foi identificada pela metodologia de PCR em 28% das amostras com genótipo CA-MRSA. Os fatores de riscos clássicos, da literatura, relacionados à infecção por HA-MRSA foram também observados nos pacientes com infecção por CA-MRSA portadoras de SCCmec IV e V. No intuito de verificar a existência de similaridades genéticas ou a presença de clone predominante entre as amostras dos cinco hospitais, foi realizada a técnica de eletroforese em gel sob campo pulsado (PFGE) e observou-se diversidade genética assim como a presença de amostras com padrões similares aos clones OSPC (18,5%) e USA400. Não foram encontradas amostras com padrões de eletroforese similares aos clones USA300, USA800 e CEB. É essencial a vigilância da resistência aos antimicrobianos não ß-lactâmicos no CA-MRSA, em especial à vancomicina. A mudança na epidemiologia deste microrganismo vem impactando os padrões característicos dos genótipos limitando os critérios de diferenciação entre eles. Neste contexto, as técnicas moleculares atuam como excelentes ferramentas de caracterização. O conhecimento do patógeno auxilia na elaboração e implementação de medidas preventivas, contribuindo para o controle da doença tanto no ambiente hospitalar quanto na comunidade. / Methicillin-resistant Staphylococcus aureus (MRSA) is a major microrganism involved in healthcare associated infections (HAIs). However, a clone of MRSA, CA-MRSA, has emerged in the community and has been considered agent of HAIs. The goal of this dissertation is to evaluate phenotypically and genotypically 111 samples of methicillin-resistant Staphylococcus aureus susceptible to non ß-lactam antibiotics from patients treated in five hospitals in the city of Rio de Janeiro. Using the Clinical and Laboratory Standards Institute criteria were determined susceptibility to 11 antimicrobials by the disk diffusion method and minimal inhibitory concentration for oxacillin and vancomycin by broth microdilution method. The multidrug resistance (resistance to three or more non ß-lactam antibiotics) was observed in 31.5% of isolates, and 53.2% were resistant to the antimicrobial clindamycin, one of the choices in the empirical treatment of infections of skin / soft tissue. 86.4% showed minimal inhibitory concentration (MIC) for vancomycin &#8805; 1.0 mg / mL, representing high percentage of samples associated with the MIC creep phenomenon, which can imply therapeutic failure. The typification of SCCmec enabled us to classify 4,5% of the samples in HA-MRSA and 86.5% in CA-MRSA, among which the typical heterogeneous oxacillin resistance was observed in 57.2%. The Panton-Valentine Leukocidin (PVL) toxin, one of the virulence factors involved in the pathogeneses of MRSA, was present in 28% of samples with genotype CA-MRSA. We performed uptake of demographic and clinical information on patients medical records and verified the presence of classical risk factors for HA-MRSA infection in individuals infected by CA-MRSA carrying SCCmec IV and V. In order to verify the existence of genetic similarities or the presence of predominant clone among the samples of the five hospitals, we applied the technique of pulsed-field gel electrophoresis (PFGE) and observed genetic diversity and the presence of samples with standards similar to OSPC clones (18.5%) and USA400. There were no samples with electrophoresis patterns similar to clone USA300, USA800 and CEB. Surveillance of resistance to non ß-lactam antibiotics is essencial in CA-MRSA, especially vancomycin. The change in the epidemiology of this microrganism has been impacting the characteristic patterns of genotypes limiting criteria of differentiation between them. In this context, molecular techniques serve as excellent characterization tools. Knowledge of pathogen assists in the development and implementation of preventive measures, contributing to disease control both in hospitals and in the community.

ABSTRACT Few antibiotics are left that are effective against methicillin-resistant Staphylococcus aureus (MRSA) and even strains resistant to these agents have been isolated. Previous studies have identified five distinct MRSA clonotypes, which are present globally. No comprehensive national study has previously been undertaken to investigate the MRSA types in South Africa, and this study was aimed at elucidating the genotypic population structure of South African MRSA isolates. SmaI digested genomic DNA, separated by pulsed-field gel electrophoresis, was used to characterise 349 S. aureus isolates, obtained from various state and private diagnostic laboratories. PFGE results were complemented with those of spa typing and staphylococcal cassette chromosome mec (SCCmec) typing results. Two-hundred-and-five different PFGE patterns were identified, which were grouped into twenty-four clusters. Three were major lineages, containing more than 20% of the isolates with a similarity cut-off of 70%. Only thirty-seven spa types were identified (fourteen novel spa types), which clustered into six spa-Clonal Complexes after BURP analysis. SCCmec types I-IV were identified, including variants of each type. Data suggest that the Archaic clone (RSA05), oldest of the epidemic clones, represents one of the major clones in South Africa. Strains that were part of this complex (n=98 (28.2%); t064; SCCmec type I-pls) clustered together with strain E2125/ATCC BAA-38 (t051; SCCmec type I). Another major complex, RSA16 (n=90 (25.7%); t012; SCCmec type II/IIB) possessed a single-locus variant (SLV) spa type and the same or a SLV SCCmec types as EMRSA-16 (t018; SCCmec type II). The third major complex, RSA03 (n=74 (21.2%); t037; SCCmec type III/IIIE), had similar spa and SCCmec types to control strainANS46 (t037; SCCmec type III). One MRSA and twelve MSSA isolates were also identified as carrying genes for the toxin Panton-Valentine leukocidin, which was confirmed by DNA nucleotide sequencing.

Methicillin-resistenta Staphylococcus aureus (MRSA) som bär på genen mecA, har förekommit och spridit sig över hela världen, främst i sjukhusmiljö, och orsakat utbrott av vårdrelaterade (så kallade nosokomiala) infektioner. Dessa infektioner kan inte behandlas med stafylokock-penicilliner och MRSA-bakterierna är ofta resistenta även mot flera andra grupper av antibiotika vilket medför att infektionerna ofta är påtagligt svårbehandlade. Under senare år har emellertid allt fler fall beskrivits av samhällsförvärvad MRSA infektion, det vill säga uppträdande av MRSA hos personer som tidigare ej har haft kontakt med sjukhusvård eller behandlats med antibiotika. Det har länge varit oklart om de samhällsförvärvade MRSA [community-acquired (CA-MRSA)] representerar spridning av bakterier från sjukhusmiljön ut till samhället eller om dessa MRSA är spontant uppträdande. Många av dessa stammar har dessutom visat sig bära på sjukdomsrelaterade gener som vanligen inte återfinns hos S. aureus, t.ex. Panton Valentine leukocidin (PVL) som associeras med hudinfektioner och allvarlig lunginflammation med hög dödlighet hos unga och annars friska individer. Denna avhandling beskriver den molekylära epidemiologin hos MRSA med fokus på samhällsförvärvade MRSA som utgjorde mer än hälften av samtliga fall av MRSA i Örebro län och som dessutom ofta producerade PVL toxinet, vars funktion vidare analyserades i detalj. Undersökning av ursprung och släktskap hos samtliga MRSA som isolerats i Örebro län, samt karaktärisering av det genetiskt element som kallas staphylococcal cassette chromosome mec (SCCmec) vilket innehåller genen mecA och ibland även andra resistensgener, visade att CA-MRSA inte är relaterade till de nosokomiala MRSA, och att dessa har uppstått oberoende av varandra. Flertalet MRSA visade sig dessutom bära på SCCmec, och resistensmekanismer, som tidigare inte beskrivits. Troligen har dessa MRSA uppstått genom ett genetiskt utbyte av SCCmec mellan methicillin-resistenta koagulas-negativa stafylokocker (MR-KNS), som utgör huvudparten av normalfloran på huden, och methicillin-känsliga S. aureus som därvid erhåller genen mecA och resistensmekanismer mot samtliga stafylokockantibiotika. I den här avhandlingen framläggs bevis för att ett sådant genetiskt utbyte har skett på Barnkliniken på Universitetssjukhuset i Örebro i slutet på 1990-talet, vilket resulterade i uppkomsten av en ny klon av MRSA som därefter orsakade ett allvarligt utbrott. Kartläggning av DNA-sekvensen hos flertalet unika SCCmec från svenska MRSA gav dessutom en bättre förståelse för hur resistens uppkommer och sprider sig, samt mekanismerna bakom detta. Dessa nya kunskaper kan bidra till en förbättrad diagnostik av MRSA. Detta är framför allt av stor betydelse eftersom nya effektiva kloner av MRSA verkar kunna uppstå ute i samhället med potential att orsaka svårbehandlade infektioner men även att sprida sig bland den friska befolkningen. / Material and methods - During a period of 14 years, around 2000 patients with head injuries were admitted to the emergency ward at Lindesberg County Hospital and Örebro Medical Centre Hospital. Six hundred subjects suffered from skull fracture and/or brain contusion and diagnosis was established using a computed tomography scan (CT). The degree of initial brain injury was estimated using the Swedish Reaction Level Scale (RLS). Sixty-six subjects were investigated with pure tone audiometry in close proximity to the trauma, and this gave an opportunity to study the issue of progress. The investigation took place two to 14 years after trauma, and the results were compared to matched control groups. A battery of different audiological methods was used to investigate peripheral and central auditory function, and a specially designed acoustic environmental room was also utilized. Cognition was investigated using a computer-based test-battery, text information process system (TIPS). Self-assessed hearing, cognition and quality of life were explored using different questionnaires. Results - A high percentage of peripheral and central auditory impairments and also cognitive shortcomings were demonstrated. Progress of SNHL was a common finding, and fracture, high age at trauma and large initial hearing loss predicted progress. Antibody-mediated autoimmunity as a mechanism behind posttraumatic progress of SNHL or clear evidence for sympathetic cochleolabyrinthitis could not be demonstrated. Binaural auditory deficits could be demonstrated when tested in a realistic acoustic environment. Tinnitus, vertigo and memory shortcomings proved to be common sequelae, even in a long-term perspectiveCognitive shortcomings were found in several of these well-rehabilitated subjects.On a group level, there was a good correlation between self-assessments and audiometric results, even if some individuals had a tendency to over- or underestimate their abilities. Conclusion - Auditory and cognitive long-term sequelae of CHI are a common finding even in well-rehabilitated and socially well-functioning subjects, as are vertigo and tinnitus. Vertigo and tinnitus are also common sequelae after CHI, therefore a basic audiovestibular investigation after CHI is recommended, at least in selected cases.Early awareness of the risk for hearing and cognitive sequelae after CHI could lead to measurements taken to prevent tension-related symptoms.Early detection of HI offers an opportunity to try immunosuppressive treatment in cases with a large initial SNHL.